Pilocarpine treatment in a mixed cohort of xerostomic patients

Oral Diseases

Volumn 13, Issue 1, 2007, Pages 88-92

  Aframian, D J ^a   Helcer, M ^a   Livni, D ^a   Robinson, S D M ^a   Markitziu, A ^a   Nadler, C ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Pilocarpine; Saliva; Salivary glands; Xerostomia

Indexed keywords

PILOCARPINE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLURRED VISION; BODY TEMPERATURE; CLINICAL ARTICLE; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; DIZZINESS; DRUG EFFICACY; DRUG WITHDRAWAL; FATIGUE; FEMALE; FLOW RATE; FLUSHING; GASTROINTESTINAL IRRITATION; HEADACHE; HEART RATE; HUMAN; HYPERSALIVATION; MALE; NAUSEA; PATIENT MONITORING; PRIORITY JOURNAL; RADIATION INJURY; RHINITIS; SALIVATION; SIDE EFFECT; SINGLE DRUG DOSE; SJOEGREN SYNDROME; SOMNOLENCE; SWEATING; TABLET; THORAX PAIN; TREMOR; URINARY FREQUENCY; VITAL SIGN; WEAKNESS; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; BODY TEMPERATURE; COHORT STUDIES; DIZZINESS; DRUG THERAPY; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MALE; MIDDLE AGED; MUSCARINIC AGONISTS; PILOCARPINE; RADIOTHERAPY; SALIVA; SECRETORY RATE; SIALADENITIS; SJOGREN'S SYNDROME; SWEATING; URINATION; XEROSTOMIA;

EID: 33846002325     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2006.01252.x     Document Type: Article

References (23)

1. Field EA, Fear S, Higham SM et al (2001). Age and medication are significant risk factors for xerostomia in an English population; attending general dental practice. Gerodontology 18: 21-24.
2. Fox PC (1998). Acquired salivary dysfunction. Drugs and radiation. Ann N Y Acad Sci 842: 132-137.
3. Fox PC (2004). Salivary enhancement therapies. Caries Res 38: 241-246.
4. Gorsky M, Epstein JB, Parry J, Epstein MS, Le ND, Silverman S Jr (2004). The efficacy of pilocarpine and bethanechol upon saliva production in cancer patients with hyposalivation following radiation therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97: 190-195.
5. Götrick B, Akerman S, Ericson D, Torstenson R, Tobin G (2004). Oral pilocarpine for treatment of opioid-induced oral dryness in healthy adults. J Dent Res 83: 393-397.
6. Hendrickson RG, Morocco AP, Greenberg MI (2004). Pilocarpine toxicity and the treatment of xerostomia. J Emerg Med 26: 429-432.
7. Izumi M, Hida A, Takagi Y, Kawabe Y, Eguchi K, Nakamura T (2000). MR imaging of the salivary glands in sicca syndrome: comparison of lipid profiles and imaging in patients with hyperlipidemia and patients with Sjogren's syndrome. AJR Am J Roentgenol 175: 829-834.
8. Kim D, Uy C, Mandel L (1998). Sialosis of unknown origin. N Y State Dent J 64: 38-40.
9. Mandel SJ, Mandel L (2003). Radioactive iodine and the salivary glands. Thyroid 13: 265-271.
10. Masters KJ (2005). Pilocarpine treatment of xerostomia induced by psychoactive medications. Am J Psychiatry 162: 1023.
11. Mercadante S (1998). Pilocarpine as an adjuvant to morphine therapy. Lancet 31: 338-9.
12. Mercadante S, Calderone L, Villari P et al (2000). The use of pilocarpine in opioid-induced xerostomia. Palliat Med 14: 529-531.
13. Nagler RM, Nagler A (1999). Pilocarpine hydrochloride relieves xerostomia in chronic graft-versus-host disease: a sialometrical study. Bone Marrow Transplant 23: 1007-1011.
14. Pedersen AM, Bardow A, Jensen SB, Nauntofte B (2002). Saliva and gastrointestinal functions of taste; mastication; swallowing and digestion. Oral Dis 8: 117-129.
15. Salah RS, Cameron OG (1996). Pilocarpine for anticholinergic adverse effects associated with desipramine treatment. Am J Psychiatry 153: 579.
16. Scully C (2003). Drug effects on salivary glands: dry mouth. Oral Dis 9: 165-176.
17. Sheikh JS, Sharma M, Kunath A, Fritz DA, Glueck CJ, Hess EV (1996). Reversible parotid enlargement and pseudo-Sjogren's syndrome secondary to hypertriglyceridemia. J Rheumatol 23: 1288-1291.
18. Ship JA (2002). Diagnosing; managing; and preventing salivary gland disorders. Oral Dis 8: 77-89.
19. Sreebny LM, Schwartz SS (1997). A reference guide to drugs and dry mouth - 2nd edition. Gerodontology 14: 33-47.
20. Sreebny LM, Valdini A (1987). Xerostomia. A neglected symptom. Arch Intern Med 147: 1333-1337.
21. Sreebny LM, Valdini A (1988). Xerostomia. Part I: relationship to other oral symptoms and salivary gland hypofunction. Oral Surg Oral Med Oral Pathol 66: 451-458.
22. Vitali C, Bombardieri S, Jonsson R et al (2002). European Study Group on Classification Criteria for Sjogren's Syndrome. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61: 554-558.
23. Wiseman LR, Faulds D (1995). Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia. Drugs 49: 143-155.